Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022

Rhea-AI Summary

Procaps Group (NASDAQ: PROC) will report its third-quarter results for the period ending September 30, 2022, on November 14, 2022, after market close. A conference call and webcast will be held on November 16, 2022, at 04 p.m. ET.

Participants can join the call using the toll-free number 1-844-204-8586 or the international number 1-412-317-6346. The conference call will be available for replay until November 25, 2022. Procaps is a prominent healthcare and pharmaceutical company operating in 13 countries and reaching over 50 countries worldwide.

MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it expects to report its results for the third quarter ended September 30, 2022, after the market closes on Monday, November 14, 2022.

The Company expects to host a conference call and webcast at 04 p.m. Eastern time, on November 16, 2022.
To access the call, please use the following information:

Date:	Wednesday, November 16, 2022
Time:	04 p.m. ET
Toll Free dial-in number:	1-844-204-8586
Toll/International dial-in number:	1-412-317-6346
Procaps HD Phone:	https://bit.ly/PROCHDPHONE
Conference ID:	Procaps Group

The conference call will be broadcast live and available for replay at https://bit.ly/Procaps3Q22 and via the investor relations section of Procaps’ website here.
A telephone replay will be available approximately two hours after the call and will run through November 25, 2022, by dialing 1-877-344-7529 from the U.S., or 1-412-317-0088 from international locations and entering replay pin number: 5225323.

About Procaps Group
Procaps Group, S.A. (“Procaps”) (NASDAQ: PROC) is a leading developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5,300 employees working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions.

For more information, visit Procaps’ investor relations website investor.procapsgroup.com.

Investor Contact:
Melissa Angelini
ir@procapsgroup.com
+1 754 260-6476
investor.procapsgroup.com

FAQ

When will Procaps report its third-quarter results for 2022?

Procaps will report its third-quarter results on November 14, 2022.

What time is the Procaps conference call on November 16, 2022?

The Procaps conference call is scheduled for 04 p.m. ET on November 16, 2022.

How can I access the Procaps conference call?

You can access the Procaps conference call by dialing 1-844-204-8586 (toll-free) or 1-412-317-6346 (international).

Is there a replay available for the Procaps conference call?

Yes, a replay of the Procaps conference call will be available until November 25, 2022.

What is Procaps Group known for?

Procaps Group is known for developing pharmaceutical and nutraceutical solutions, operating in over 50 countries.